American Express (AXP) Stock: Analyst Urges Patience Ahead of Q1 Earnings

Key Takeaways

• American Express delivers Q1 results on April 23, with analysts projecting approximately 9.6% year-over-year increases in both earnings per share and revenue
• Billed business (cardholder spending) expanded 8% YoY during Q4 2025, though momentum has stalled without signs of renewed acceleration
• Credit metrics hold firm — charge-offs climbed modestly while reserve additions have tapered
• Full-year 2026 outlook projects 9–10% revenue expansion with EPS ranging from $17.30 to $17.90, aligning closely with Street forecasts
• Analyst consensus leans toward Moderate Buy, with a mean price target of $352.60 (approximately 6.3% potential gain)

As American Express (AXP) approaches its Q1 2026 earnings release on April 23, the company finds itself in a position many would describe as stable — though that stability may be the very issue investors need to consider.

American Express Company, AXP

The fundamentals paint a reassuring picture. Consumer spending remains resilient. Credit metrics show no red flags. Yet for a stock commanding a premium valuation, merely satisfactory performance may not justify the price tag.

Analyst projections point to roughly 9.6% annual growth in both earnings and revenue. While consistent, this trajectory lacks the spark that typically drives significant stock appreciation.

The central challenge revolves around billed business — the volume of cardholder spending — which represents the most scrutinized performance indicator for AXP. This metric advanced 8% YoY in Q4 2025, matching the pace maintained throughout fiscal 2025. However, after climbing from 6% in Q1 2025 to 7% in Q2, expansion has plateaued.

This pattern increasingly resembles a mature business experiencing predictable growth — a characterization that clashes with the stock’s 21.4x trailing price-to-earnings ratio.

Credit Metrics Show Resilience, Not Weakness

Examining credit performance reveals little cause for concern. Charge-offs reached $1.27 billion in Q4, rising from $1.13 billion the previous year, yet the quarter-over-quarter increase remained manageable.

Provisions ticked higher to $1.41 billion compared to $1.28 billion in Q3. Notably, the reserve build totaled just $141 million — substantially below the $222 million recorded in Q2 2025. This shift signals prudent adjustment rather than emerging risk.

Net interest income climbed 12% annually, loan balances expanded 7%, and margins widened. These indicators point to credit expansion that remains both profitable and disciplined. The appropriate interpretation is stabilization rather than stress.

Cramer’s Take on Timing

Jim Cramer addressed AXP during a recent Mad Money segment, offering a tactical recommendation for potential investors ahead of the earnings announcement.

“American Express almost always seems to retreat when we see the numbers and then runs a couple of days later,” Cramer observed. His strategy: hold off until earnings day concludes — or wait until the following morning — to sidestep the “knee-jerk selling” that frequently follows even strong quarterly reports.

Cramer has also highlighted AXP’s affluent customer demographic as a lasting advantage. “Demand for premium products can stay strong even if the rest of the economy slows down,” he noted in early April.

Bank of America’s Q1 report, released April 15, provides useful context on consumer spending patterns. Card volumes rose 6% YoY, driven primarily by travel, services, and retail categories. Given Amex’s tilt toward higher-income consumers, comparable or superior performance seems probable — establishing high single-digit billed business growth as the baseline expectation for Q1.

AXP currently trades at approximately 18.5x forward earnings, representing roughly a 20% discount from its December valuation peak. This multiple compression moderately improves the risk-reward profile.

The company’s fiscal 2026 guidance anticipates 9–10% revenue growth with EPS between $17.30 and $17.90 — translating to about 14% annual earnings growth. Analysts have largely maintained their projections following this outlook.

Among the most recent 17 analyst ratings, seven recommend Buy, nine suggest Hold, and one advises Sell. The consensus price target stands at $352.60, indicating roughly 6.3% upside from present levels.